1155368-40-3

Downstream Products

• 1286689-79-9 C₂₃H₃₄N₂O₇ 
• 1286689-84-6 C₂₃H₃₈N₂O₇ 
• 1286690-24-1 C₃₅H₅₄N₂O₇ 
• 1286690-28-5 C₂₅H₃₆N₂O₇ 
• 1286689-90-4 C₃₅H₅₀N₂O₇ 
• 1286690-26-3 C₃₅H₅₀N₂O₇ 
• 1286689-92-6 C₂₉H₃₈N₂O₇ 
• 1286689-98-2 C₂₉H₄₂N₂O₇ 
• 1286690-06-9 3-(3-((7,7-dimethyl-2-oxobicyclo[2.2.1]heptan-1-yl)methylsulfonamido)propanamido)-2,4-dihydroxybenzoic acid 
• 1286690-29-6 3-(3-(((1R,5S)-6,6-dimethylbicyclo[3.1.1]hept-2-en-2-yl)methylamino)propanamido)-2,4-dihydroxybenzoic acid 
• 1287267-60-0 (+)-myrtamycin 
• 1286690-04-7 2,4-dihydroxy-3-(3-(adamantan-2-ylamino)propanamido)benzoic acid 
• 1286689-99-3 3-(3-(bis(cyclohex-1-en-1-ylmethyl)amino)propanamido)-2,4-dihydroxybenzoic acid 
• 1286689-93-7 3-(3-(di(bicyclo[3.2.0]hept-3-en-6-yl)amino)propanamido)-2,4-dihydroxybenzoic acid 

Relevant academic research and scientific papers

Efforts towards the identification of simpler platensimycin analogues-the total synthesis of oxazinidinyl platensimycin

The total synthesis and biological testing of oxazinidinyl platensimycin, the methyl ester analogues, and the simplified oxazinidinyl analogue were investigated to identify simpler platensimycin analogues. The study also investigated the possibilities of replacing enone moiety of platensimycin with the oxazinidinyl ring to create a potential bioisostere compound. The study examined the possibilities to replace the tetracyclic core structure of platensimycin with other motifs that are synthetically easier to access. Proposed methods can applied to the construction of other polycyclic motifs found in the other natural or non-natural molecules. The results show that the enone moiety of platensimycin's core structure is sensitive to modifications.